Drugs used to treat systemic lupus erythematosus.
This report contains market size and forecasts of Systemic Lupus Erythematosus (SLE) Medication in global, including the following market information:
Global Systemic Lupus Erythematosus (SLE) Medication Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Systemic Lupus Erythematosus (SLE) Medication Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Systemic Lupus Erythematosus (SLE) Medication companies in 2021 (%)
The global Systemic Lupus Erythematosus (SLE) Medication market was valued at 200 million in 2021 and is projected to reach US$ 272.6 million by 2028, at a CAGR of 4.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Systemic Lupus Erythematosus (SLE) Medication include GSK, ImmuPharma, Merck Serono, UCB, Amgen, HGS, Immunomedics, MedImmune and Sanofi. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Systemic Lupus Erythematosus (SLE) Medication manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Systemic Lupus Erythematosus (SLE) Medication Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Systemic Lupus Erythematosus (SLE) Medication Market Segment Percentages, by Type, 2021 (%)
Corticosteroids
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Anti-Inflammatories
Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
Antimalarials
BLyS-specific Inhibitors or Monoclonal Antibodies (MAbS)
Immunosuppressive Agents/Immune Modulators
Anticoagulants
Global Systemic Lupus Erythematosus (SLE) Medication Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Systemic Lupus Erythematosus (SLE) Medication Market Segment Percentages, by Application, 2021 (%)
Intravenous
Oral
Topical
Others
Global Systemic Lupus Erythematosus (SLE) Medication Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Systemic Lupus Erythematosus (SLE) Medication Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Systemic Lupus Erythematosus (SLE) Medication revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Systemic Lupus Erythematosus (SLE) Medication revenues share in global market, 2021 (%)
Key companies Systemic Lupus Erythematosus (SLE) Medication sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Systemic Lupus Erythematosus (SLE) Medication sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
ImmuPharma
Merck Serono
UCB
Amgen
HGS
Immunomedics
MedImmune
Sanofi